| VRTX | Vertex Pharmaceuticals Inc | $121.26B | +237429.97% |
| VRNA | Verona Pharma Plc | $77.75B | +152199.75% |
| REGN | Regeneron Pharmaceuticals Inc | $69.10B | +135265.78% |
| ARGX | Argen X SE | $57.12B | +111799.24% |
| ALNY | Alnylam Pharmaceuticals Inc | $36.95B | +72284.33% |
| RVMD | Revolution Medicines Inc | $36.92B | +72224.60% |
| ONC | BeiGene Ltd | $36.03B | +70489.09% |
| MRNA | Moderna Inc | $27.11B | +53000.34% |
| ROIV | Roivant Sciences Ltd | $25.13B | +49133.33% |
| RPRX | Royalty Pharma plc - Class A | $24.60B | +48080.52% |
| INSM | Insmed Inc | $23.78B | +46475.43% |
| BNTX | BioNTech SE | $23.26B | +45469.65% |
| GMAB | Genmab | $18.57B | +36275.20% |
| ASND | Ascendis Pharma A/S | $17.33B | +33845.19% |
| BBIO | BridgeBio Pharma Inc | $16.18B | +31589.59% |
| JAZZ | Jazz Pharmaceuticals plc | $14.81B | +28919.03% |
| EXEL | Exelixis Inc | $14.09B | +27507.02% |
| MDGL | Madrigal Pharmaceuticals Inc | $12.68B | +24736.59% |
| AXSM | Axsome Therapeutics Inc | $12.21B | +23825.86% |
| SMMT | Summit Therapeutics Inc | $11.69B | +22808.57% |
| BMRN | Biomarin Pharmaceutical Inc | $11.39B | +22218.19% |
| TECH | Bio-Techne Corp | $11.19B | +21815.77% |
| ABVX | Abivax | $10.86B | +21170.05% |
| KRYS | Krystal Biotech Inc | $10.31B | +20096.33% |
| CYTK | Cytokinetics Inc | $10.18B | +19851.08% |
| ARWR | Arrowhead Pharmaceuticals Inc | $10.10B | +19676.73% |
| APGE | Apogee Therapeutics Inc | $10.06B | +19598.66% |
| NUVL | Nuvalent Inc - Class A | $9.75B | +19003.20% |
| KYMR | Kymera Therapeutics Inc | $9.38B | +18271.82% |
| CORT | Corcept Therapeutics Inc | $9.35B | +18224.07% |
| IONS | Ionis Pharmaceuticals Inc | $9.08B | +17686.50% |
| HALO | Halozyme Therapeutics Inc | $8.99B | +17503.53% |
| PRAX | Praxis Precision Medicines Inc | $8.87B | +17277.49% |
| CRNX | Crinetics Pharmaceuticals Inc | $8.84B | +17208.57% |
| PTGX | Protagonist Therapeutics Inc | $8.70B | +16942.85% |
| TGTX | TG Therapeutics Inc | $8.64B | +16817.15% |
| PCVX | Vaxcyte Inc | $8.19B | +15940.36% |
| IMVT | Immunovant Inc | $8.13B | +15832.05% |
| IBRX | ImmunityBio Inc | $8.10B | +15759.19% |
| SYRE | Spyre Therapeutics Inc | $8.05B | +15663.66% |
| RYTM | Rhythm Pharmaceuticals Inc | $7.51B | +14606.95% |
| MTSR | Metsera Inc | $7.40B | +14404.99% |
| MIRM | Mirum Pharmaceuticals Inc | $7.37B | +14341.17% |
| MRUS | Merus N.V | $6.83B | +13270.86% |
| COGT | Cogent Biosciences Inc | $6.71B | +13047.01% |
| ACLX | Arcellx Inc | $6.67B | +12957.91% |
| XENE | Xenon Pharmaceuticals Inc | $6.54B | +12715.97% |
| PTCT | PTC Therapeutics Inc | $6.53B | +12700.30% |
| CDTX | Cidara Therapeutics Inc | $6.49B | +12621.65% |
| SRRK | Scholar Rock Holding Corp | $6.44B | +12508.23% |
| CGON | Cg Oncology Inc | $6.42B | +12485.11% |
| CNTA | Centessa Pharmaceuticals plc | $6.27B | +12175.52% |
| TERN | Terns Pharmaceuticals Inc | $5.95B | +11550.76% |
| LGND | Ligand Pharmaceuticals Inc - Class B | $5.93B | +11523.73% |
| BLTE | Belite Bio Inc | $5.88B | +11418.64% |
| ERAS | Erasca Inc | $5.51B | +10686.63% |
| DNTH | Dianthus Therapeutics Inc | $5.45B | +10582.62% |
| APLS | Apellis Pharmaceuticals Inc | $5.25B | +10181.66% |
| TVTX | Travere Therapeutics Inc | $5.24B | +10170.51% |
| CRSP | CRISPR Therapeutics AG | $4.95B | +9599.17% |
| CAI | Caris Life Sciences Inc - Class A | $4.94B | +9567.35% |
| FOLD | Amicus Therapeutics Inc | $4.50B | +8723.44% |
| ACAD | Acadia Pharmaceuticals Inc | $4.43B | +8586.87% |
| CELC | Celcuity Inc | $4.42B | +8566.72% |
| EWTX | Edgewise Therapeutics Inc | $4.39B | +8496.59% |
| VKTX | Viking Therapeutics Inc | $4.38B | +8483.82% |
| AKRO | Akero Therapeutics Inc | $4.38B | +8480.30% |
| TNGX | Tango Therapeutics Inc | $4.36B | +8442.62% |
| ORKA | ARCA biopharma Inc | $4.35B | +8415.41% |
| LEGN | Legend Biotech Corp | $4.26B | +8237.59% |
| DYN | Dyne Therapeutics Inc | $3.96B | +7663.49% |
| CPRX | Catalyst Pharmaceuticals Inc | $3.85B | +7436.86% |
| TLX | Telix Pharmaceuticals Ltd | $3.82B | +7392.42% |
| NAMS | NewAmsterdam Pharma Company NV | $3.73B | +7207.11% |
| RLAY | Relay Therapeutics Inc | $3.69B | +7131.25% |
| DNLI | Denali Therapeutics Inc | $3.65B | +7054.44% |
| ALMS | Alumis Inc | $3.60B | +6957.36% |
| GPCR | Structure Therapeutics Inc | $3.53B | +6808.00% |
| RCUS | Arcus Biosciences Inc | $3.52B | +6788.51% |
| ARQT | Arcutis Biotherapeutics Inc | $3.47B | +6704.58% |
| ELVN | Enliven Therapeutics Inc | $3.24B | +6240.77% |
| IDYA | Ideaya Biosciences Inc | $3.23B | +6223.02% |
| BEAM | Beam Therapeutics Inc | $3.17B | +6106.90% |
| RARE | Ultragenyx Pharmaceutical Inc | $3.12B | +6006.09% |
| VERA | Vera Therapeutics Inc - Class A | $3.04B | +5850.67% |
| IRON | Disc Medicine Inc | $2.90B | +5587.17% |
| MBX | MBX Biosciences Inc | $2.89B | +5554.06% |
| SLNO | Soleno Therapeutics Inc | $2.74B | +5270.49% |
| KOD | Kodiak Sciences Inc | $2.64B | +5064.93% |
| IMNM | Immunome Inc | $2.59B | +4981.18% |
| QURE | uniQure N.V. | $2.58B | +4962.52% |
| CLDX | Celldex Therapeutics Inc | $2.55B | +4895.71% |
| TARS | Tarsus Pharmaceuticals Inc | $2.47B | +4745.79% |
| NRIX | Nurix Therapeutics Inc | $2.47B | +4744.92% |
| MLYS | Mineralys Therapeutics Inc | $2.43B | +4663.66% |
| VCEL | Vericel Corp | $2.38B | +4568.44% |
| AGIO | Agios Pharmaceuticals Inc | $2.37B | +4534.65% |
| MESO | Mesoblast Ltd | $2.36B | +4516.54% |
| ETNB | 89bio Inc | $2.34B | +4489.60% |
| TRVI | Trevi Therapeutics Inc | $2.33B | +4464.28% |
| SLS | SELLAS Life Sciences Group Inc | $2.32B | +4443.18% |
| PHVS | Pharvaris NV | $2.30B | +4397.91% |
| ZLAB | Zai Lab Ltd | $2.27B | +4345.37% |
| BHVN | Biohaven Ltd | $2.24B | +4284.09% |
| DAWN | Day One Biopharmaceuticals Inc | $2.22B | +4243.32% |
| OCUL | Ocular Therapeutix Inc | $2.18B | +4170.83% |
| PVLA | Palvella Therapeutics Inc | $2.18B | +4161.10% |
| AUPH | Aurinia Pharmaceuticals Inc | $2.11B | +4024.30% |
| SNDX | Syndax Pharmaceuticals Inc | $2.08B | +3979.52% |
| IOVA | Iovance Biotherapeutics Inc | $2.08B | +3967.91% |
| ABCL | AbCellera Biologics Inc | $2.05B | +3913.00% |
| NUVB | Nuvation Bio Inc - Class A | $2.04B | +3904.73% |
| HRMY | Harmony Biosciences Holdings Inc | $2.02B | +3856.15% |
| ADMA | Adma Biologics Inc | $2.02B | +3849.68% |
| SION | Sionna Therapeutics Inc | $2.00B | +3818.70% |
| GLUE | Monte Rosa Therapeutics Inc | $1.97B | +3766.82% |
| ATAI | ATAI Life Sciences N.V. | $1.96B | +3738.31% |
| VRDN | Viridian Therapeutics Inc | $1.95B | +3725.45% |
| URGN | UroGen Pharma Ltd | $1.94B | +3697.51% |
| TYRA | Tyra Biosciences Inc | $1.93B | +3672.12% |
| NBTX | Nanobiotix | $1.91B | +3643.22% |
| RAPP | Rapport Therapeutics Inc | $1.91B | +3639.45% |
| GLPG | Galapagos NV | $1.90B | +3618.52% |
| AAPG | Ascentage Pharma Group International | $1.87B | +3560.66% |
| STOK | Stoke Therapeutics Inc | $1.86B | +3546.71% |
| SRPT | Sarepta Therapeutics Inc | $1.86B | +3541.81% |
| BCAX | Bicara Therapeutics Inc | $1.84B | +3509.98% |
| ZBIO | Zenas Biopharma Inc | $1.83B | +3493.99% |
| PGEN | Precigen Inc | $1.82B | +3469.57% |
| ZYME | Zymeworks BC Inc | $1.80B | +3431.34% |
| TSHA | Taysha Gene Therapies Inc | $1.78B | +3383.41% |
| IMCR | Immunocore Holdings plc | $1.76B | +3353.26% |
| RXRX | Recursion Pharmaceuticals Inc - Class A | $1.76B | +3340.58% |
| FTRE | Fortrea Holdings Inc | $1.69B | +3218.94% |
| NKTR | Nektar Therapeutics | $1.69B | +3209.52% |
| MPLT | MapLight Therapeutics Inc | $1.69B | +3205.94% |
| GHRS | GH Research PLC | $1.67B | +3171.28% |
| ANAB | AnaptysBio Inc | $1.62B | +3074.40% |
| INVA | Innoviva Inc | $1.62B | +3064.92% |
| NTLA | Intellia Therapeutics Inc | $1.57B | +2976.73% |
| RAPT | RAPT Therapeutics Inc | $1.56B | +2964.51% |
| VIR | Vir Biotechnology Inc | $1.55B | +2935.24% |
| SEPN | Septerna Inc | $1.53B | +2897.73% |
| AVBP | ArriVent BioPharma Inc | $1.49B | +2824.51% |
| ABSI | Absci Corp | $1.49B | +2824.46% |
| MAZE | Maze Therapeutics Inc | $1.46B | +2763.50% |
| MLTX | MoonLake Immunotherapeutics - Class A | $1.42B | +2686.78% |
| NVAX | Novavax Inc | $1.39B | +2615.20% |
| KALV | KalVista Pharmaceuticals Inc | $1.38B | +2609.97% |
| INBX | Inhibrx Biosciences Inc | $1.33B | +2510.19% |
| ARDX | Ardelyx Inc | $1.31B | +2464.13% |
| IMTX | Immatics N.V | $1.28B | +2397.77% |
| MNKD | Mannkind Corp | $1.26B | +2374.94% |
| ANNX | Annexon Inc | $1.26B | +2372.73% |
| CRVS | Corvus Pharmaceuticals Inc | $1.25B | +2357.70% |
| TRML | Tourmaline Bio Inc | $1.24B | +2320.67% |
| SVRA | Savara Inc | $1.19B | +2232.27% |
| CAPR | Capricor Therapeutics Inc | $1.17B | +2198.73% |
| EYPT | EyePoint Pharmaceuticals Inc | $1.16B | +2164.15% |
| ORIC | ORIC Pharmaceuticals Inc | $1.15B | +2158.30% |
| WVE | Wave Life Sciences Ltd | $1.14B | +2126.72% |
| XNCR | Xencor Inc | $1.11B | +2073.36% |
| DRTS | Alpha Tau Medical Ltd | $1.10B | +2048.14% |
| CGEM | Cullinan Oncology Inc | $1.10B | +2046.33% |
| JBIO | Jade Biosciences Inc | $1.08B | +2013.08% |
| CVAC | CureVac N.V. | $1.05B | +1955.49% |
| OLMA | Olema Pharmaceuticals Inc | $1.03B | +1922.13% |
| MGTX | MeiraGTx Holdings plc | $1.02B | +1903.89% |
| KURA | Kura Oncology Inc | $1.01B | +1870.04% |
| VTYX | Ventyx Biosciences Inc | $998.72M | +1856.39% |
| GRCL | Gracell Biotechnologies Inc | $989.87M | +1839.05% |
| VOR | Vor Biopharma Inc | $979.68M | +1819.09% |
| JANX | Janux Therapeutics Inc | $975.67M | +1811.25% |
| ANRO | Alto Neuroscience Inc | $973.06M | +1806.14% |
| SANA | Sana Biotechnology Inc | $957.85M | +1776.34% |
| GERN | Geron Corp | $950.51M | +1761.96% |
| SLDB | Solid Biosciences Inc | $946.56M | +1754.22% |
| PHAR | Pharming Group N.V. | $939.88M | +1741.14% |
| LXRX | Lexicon Pharmaceuticals Inc | $936.56M | +1734.63% |
| DBVT | DBV Technologies | $930.17M | +1722.11% |
| LBRX | LB Pharmaceuticals Inc | $922.18M | +1706.47% |
| ABUS | Arbutus Biopharma Corp | $898.08M | +1659.26% |
| PHAT | Phathom Pharmaceuticals Inc | $877.84M | +1619.60% |
| TBPH | Theravance Biopharma Inc | $872.15M | +1608.46% |
| DSGN | Design Therapeutics Inc | $844.21M | +1553.72% |
| REPL | Replimune Group Inc | $800.70M | +1468.49% |
| ACRS | Aclaris Therapeutics Inc | $782.06M | +1431.97% |
| OCS | Oculis Holding AG | $772.84M | +1413.91% |
| ZVRA | Zevra Therapeutics Inc | $766.13M | +1400.77% |
| CMRX | Chimerix Inc | $766.03M | +1400.58% |
| RIGL | Rigel Pharmaceuticals | $758.21M | +1385.25% |
| SPRY | ARS Pharmaceuticals Inc | $749.72M | +1368.62% |
| OMER | Omeros Corporation | $746.63M | +1362.57% |
| MNPR | Monopar Therapeutics Inc | $728.12M | +1326.32% |
| DRUG | Bright Minds Biosciences Inc | $728.06M | +1326.20% |
| ATXS | Astria Therapeutics Inc | $709.95M | +1290.73% |
| CADL | Candel Therapeutics Inc | $706.21M | +1283.39% |
| XOMA | XOMA Royalty Corp | $699.64M | +1270.53% |
| BBOT | BridgeBio Oncology Therapeutics Inc Com | $673.55M | +1219.42% |
| CLYM | Eliem Therapeutics Inc | $662.55M | +1197.87% |
| CRMD | CorMedix Inc | $660.09M | +1193.05% |
| IVA | Inventiva | $655.21M | +1183.50% |
| CTMX | CytomX Therapeutics Inc | $652.36M | +1177.92% |
| RLMD | Relmada Therapeutics Inc | $651.37M | +1175.97% |
| MDXG | Mimedx Group Inc | $635.94M | +1145.74% |
| RGNX | Regenxbio Inc | $633.34M | +1140.65% |
| PRME | Prime Medicine Inc | $630.35M | +1134.79% |
| NGNE | Neoleukin Therapeutics Inc | $616.04M | +1106.77% |
| TECX | AvroBio Inc | $611.99M | +1098.83% |
| FDMT | 4D Molecular Therapeutics Inc | $610.53M | +1095.98% |
| GYRE | Gyre Therapeutics Inc | $599.17M | +1073.72% |
| IMMX | Immix Biopharma Inc | $558.22M | +993.49% |
| DNA | Ginkgo Bioworks Holdings Inc - Class A | $555.56M | +988.30% |
| CTNM | Contineum Therapeutics Inc - Class A | $546.27M | +970.09% |
| ARVN | Arvinas Inc | $534.06M | +946.17% |
| NVCT | Nuvectis Pharma Inc | $519.64M | +917.92% |
| STTK | Shattuck Labs Inc | $511.69M | +902.35% |
| ZURA | Zura Bio Ltd - Class A | $511.41M | +901.80% |
| VSTM | Verastem Inc | $503.34M | +886.00% |
| SLN | Silence Therapeutics Plc | $493.60M | +866.92% |
| OCGN | Ocugen Inc | $483.80M | +847.71% |
| KYTX | Kyverna Therapeutics Inc | $470.94M | +822.53% |
| ALLO | Allogene Therapeutics Inc | $465.15M | +811.19% |
| SVA | Sinovac Biotech Ltd | $464.94M | +810.77% |
| CABA | Cabaletta Bio Inc | $463.15M | +807.27% |
| RZLT | Rezolute Inc | $456.43M | +794.09% |
| MRVI | Maravai LifeSciences Holdings Inc - Class A | $451.41M | +784.27% |
| EVMN | Evommune Inc | $447.71M | +777.02% |
| PRTA | Prothena Corporation plc | $447.44M | +776.49% |
| BNTC | Benitec Biopharma Inc | $447.29M | +776.21% |
| VALN | Valneva SE | $440.98M | +763.83% |
| CBIO | N/A | $432.05M | +746.35% |
| STRO | Sutro Biopharma Inc | $430.74M | +743.77% |
| AURA | Aura Biosciences Inc | $430.49M | +743.29% |
| PBYI | Puma Biotechnology Inc | $427.89M | +738.20% |
| ASMB | Assembly Biosciences Inc | $424.80M | +732.15% |
| OVID | Ovid Therapeutics Inc | $416.49M | +715.87% |
| ABEO | Abeona Therapeutics Inc | $414.56M | +712.08% |
| DMAC | DiaMedica Therapeutics Inc | $411.67M | +706.42% |
| CYBN | Cybin Inc | $408.43M | +700.08% |
| AVTX | Avalo Therapeutics Inc | $403.76M | +690.93% |
| AUTL | Autolus Therapeutics plc | $401.88M | +687.24% |
| RCKT | Rocket Pharmaceuticals Inc | $398.30M | +680.23% |
| LRMR | Larimar Therapeutics Inc | $395.79M | +675.32% |
| UPB | Upstream Bio Inc | $395.63M | +675.01% |
| CCCC | C4 Therapeutics Inc | $395.34M | +674.43% |
| IPSC | Century Therapeutics Inc | $390.82M | +665.58% |
| YMAB | Y-Mabs Therapeutics Inc | $390.19M | +664.34% |
| AVIR | Atea Pharmaceuticals Inc | $388.93M | +661.88% |
| CMPX | Compass Therapeutics Inc | $385.39M | +654.94% |
| ENTA | Enanta Pharmaceuticals Inc | $384.48M | +653.15% |
| RVNC | Revance Therapeutics Inc | $380.38M | +645.12% |
| PRTC | PureTech Health plc American Depositary Shares | $376.98M | +638.48% |
| ALT | Altimmune Inc | $373.67M | +631.99% |
| TENX | Tenax Therapeutics Inc | $372.39M | +629.47% |
| PRLD | Prelude Therapeutics Inc | $368.04M | +620.95% |
| XFOR | X4 Pharmaceuticals Inc | $367.85M | +620.58% |
| FENC | Fennec Pharmaceuticals Inc | $366.13M | +617.22% |
| VNDA | Vanda Pharmaceuticals Inc | $351.79M | +589.12% |
| LXEO | Lexeo Therapeutics Inc | $351.17M | +587.91% |
| EDIT | Editas Medicine Inc | $349.39M | +584.41% |
| FATE | Fate Therapeutics Inc | $347.65M | +581.02% |
| FBRX | Forte Biosciences Inc | $340.15M | +566.33% |
| ZNTL | Zentalis Pharmaceuticals Inc | $340.13M | +566.27% |
| PALI | Palisade Bio Inc | $339.87M | +565.77% |
| IMAB | I-Mab | $339.64M | +565.31% |
| EPRX | Eupraxia Pharmaceuticals Inc | $338.64M | +563.37% |
| IMRX | Immuneering Corp Class A | $333.64M | +553.57% |
| LYEL | Lyell Immunopharma Inc | $332.66M | +551.65% |
| FHTX | Foghorn Therapeutics Inc | $319.97M | +526.79% |
| INDP | Indaptus Therapeutics Inc | $319.34M | +525.56% |
| ANL | Adlai Nortye Ltd | $317.46M | +521.86% |
| GALT | Galectin Therapeutics Inc | $313.48M | +514.08% |
| LCTX | Lineage Cell Therapeutics Inc | $305.39M | +498.23% |
| VTVT | vTv Therapeutics Inc - Class A | $305.06M | +497.58% |
| ELDN | Eledon Pharmaceuticals Inc | $304.92M | +497.32% |
| SCPH | scPharmaceuticals Inc | $304.59M | +496.66% |
| ARTV | Artiva Biotherapeutics Inc | $302.86M | +493.28% |
| OABI | OmniAb Inc | $301.15M | +489.92% |
| BCYC | Bicycle Therapeutics Plc | $294.16M | +476.24% |
| NMRA | Neumora Therapeutics Inc | $293.19M | +474.33% |
| GLSI | Greenwich LifeSciences Inc | $286.57M | +461.37% |
| TTRX | Turn Therapeutics Inc | $285.37M | +459.01% |
| CLLS | Cellectis | $282.48M | +453.35% |
| TRDA | Entrada Therapeutics Inc | $276.01M | +440.69% |
| NAGE | Niagen Bioscience Inc | $275.72M | +440.10% |
| MGNX | Macrogenics Inc | $274.58M | +437.87% |
| SABS | SAB Biotherapeutics Inc | $274.20M | +437.12% |
| ALXO | Alx Oncology Holdings Inc | $273.12M | +435.01% |
| IKT | Inhibikase Therapeutics Inc | $271.99M | +432.80% |
| SRZN | Surrozen Inc | $250.37M | +390.45% |
| IRD | Ocuphire Pharma Inc | $248.48M | +386.75% |
| RNAC | Cartesian Therapeutics Inc | $247.77M | +385.35% |
| THRD | Third Harmonic Bio Inc | $241.86M | +373.79% |
| FULC | Fulcrum Therapeutics Inc | $237.12M | +364.50% |
| GNFT | GENFIT S.A. American Depositary Shares | $233.01M | +356.45% |
| ACIU | AC Immune SA | $232.87M | +356.17% |
| AVXL | Anavex Life Sciences Corporation | $231.68M | +353.84% |
| IVVD | Invivyd Inc | $231.05M | +352.61% |
| QTTB | Q32 Bio Inc | $229.68M | +349.93% |
| SLRN | Acelyrin Inc | $228.54M | +347.70% |
| DTIL | Precision Biosciences Inc | $227.35M | +345.36% |
| TARA | Protara Therapeutics Inc | $226.83M | +344.34% |
| CGEN | Compugen Ltd | $223.15M | +337.12% |
| CHRS | Coherus Biosciences Inc | $222.07M | +335.02% |
| NAUT | Nautilus Biotechnology Inc | $221.10M | +333.12% |
| CAMP | CAMP4 Therapeutics Corp | $218.61M | +328.23% |
| KROS | Keros Therapeutics Inc | $217.65M | +326.36% |
| ADAG | Adagene Inc | $217.38M | +325.83% |
| SLGL | Sol-Gel Technologies Ltd | $215.10M | +321.37% |
| KPTI | Karyopharm Therapeutics Inc | $214.84M | +320.86% |
| OBIO | Orchestra BioMed Holdings Inc | $214.00M | +319.21% |
| RNA | Atrium Therapeutics Inc | $210.40M | +312.15% |
| IMUX | Immunic Inc | $205.68M | +302.92% |
| TLSA | Tiziana Life Sciences Ltd | $201.81M | +295.32% |
| CDXS | Codexis Inc | $200.88M | +293.50% |
| NKTX | Nkarta Inc | $197.53M | +286.93% |
| AGEN | Agenus Inc | $192.99M | +278.06% |
| VYGR | Voyager Therapeutics Inc | $192.99M | +278.06% |
| NERV | Minerva Neurosciences Inc | $189.40M | +271.01% |
| KRRO | Korro Bio Inc | $187.93M | +268.13% |
| PRQR | ProQR Therapeutics N.V | $186.49M | +265.32% |
| PLX | Protalix BioTherapeutics Inc | $186.05M | +264.45% |
| TNYA | Tenaya Therapeutics Inc | $182.97M | +258.43% |
| MDWD | MediWound Ltd | $182.55M | +257.61% |
| IFRX | InflaRx N.V. | $182.18M | +256.87% |
| WHWK | Whitehawk Therapeutics Inc | $181.71M | +255.95% |
| ARCT | Arcturus Therapeutics Holdings Inc | $181.62M | +255.78% |
| SGMT | Sagimet Biosciences Inc - Class A | $180.81M | +254.19% |
| ACOG | Alpha Cognition Inc | $180.73M | +254.02% |
| MENS | Jyong Biotech Ltd | $174.10M | +241.05% |
| ACHV | Achieve Life Sciences Inc | $173.54M | +239.95% |
| PEPG | PepGen Inc | $168.86M | +230.78% |
| ANTX | AN2 Therapeutics Inc | $168.05M | +229.20% |
| CRBU | Caribou Biosciences Inc | $167.73M | +228.56% |
| THTX | Theratechnologies Inc | $167.34M | +227.80% |
| ALEC | Alector Inc | $166.54M | +226.23% |
| ORMP | Oramed Pharmaceuticals Inc | $166.16M | +225.49% |
| EQ | Equillium Inc | $165.65M | +224.50% |
| TNXP | Tonix Pharmaceuticals Holding Corp | $164.92M | +223.07% |
| IPHA | Innate Pharma | $164.54M | +222.32% |
| OTLK | Outlook Therapeutics Inc | $163.20M | +219.69% |
| YDES | YD Bio Ltd | $160.69M | +214.78% |
| ABOS | Acumen Pharmaceuticals Inc | $160.35M | +214.10% |
| CRBP | Corbus Pharmaceuticals Holdings Inc | $159.83M | +213.09% |
| LENZ | LENZ Therapeutics Inc | $156.46M | +206.49% |
| PYXS | Pyxis Oncology Inc | $152.68M | +199.09% |
| CNTB | Connect Biopharma Holdings Ltd | $152.39M | +198.52% |
| HUMA | Humacyte Inc | $151.33M | +196.44% |
| MIST | Milestone Pharmaceuticals Inc | $149.60M | +193.05% |
| NBP | NovaBridge Biosciences. | $149.30M | +192.46% |
| NRXP | NRX Pharmaceuticals Inc | $149.28M | +192.43% |
| AKTX | Akari Therapeutics Plc | $148.12M | +190.16% |
| MOLN | Molecular Partners AG | $146.63M | +187.24% |
| ARMP | Armata Pharmaceuticals Inc | $146.49M | +186.95% |
| AARD | Aardvark Therapeutics Inc | $145.52M | +185.05% |
| MRSN | Mersana Therapeutics Inc | $145.36M | +184.74% |
| HURA | TuHURA Biosciences Inc | $144.96M | +183.96% |
| GUTS | Fractyl Health Inc | $144.37M | +182.81% |
| PROK | ProKidney Corp - Class A | $137.85M | +170.04% |
| TCRX | Tscan Therapeutics Inc | $137.63M | +169.60% |
| CBUS | Cibus Global Ltd. Class A | $135.62M | +165.67% |
| THAR | Tharimmune Inc | $135.41M | +165.25% |
| SEER | Seer Inc - Class A | $132.16M | +158.89% |
| GNLX | Genelux Corp | $130.49M | +155.61% |
| VXRT | Vaxart Inc | $127.95M | +150.64% |
| ENGN | enGene Holdings Inc | $127.28M | +149.33% |
| UNCY | Unicycive Therapeutics Inc | $126.69M | +148.18% |
| PMN | ProMIS Neurosciences Inc | $125.59M | +146.02% |
| FBIO | Fortress Biotech Inc | $123.12M | +141.19% |
| RANI | Rani Therapeutics Holdings Inc Class A | $121.86M | +138.71% |
| VANI | Vivani Medical Inc | $119.35M | +133.80% |
| ANIX | Anixa Biosciences Inc | $118.73M | +132.58% |
| ALDX | Aldeyra Therapeutics Inc | $115.82M | +126.87% |
| SAVA | Cassava Sciences Inc. | $114.97M | +125.22% |
| RPTX | Repare Therapeutics Inc | $113.91M | +123.14% |
| COYA | Coya Therapeutics Inc | $113.53M | +122.40% |
| KLRS | Kalaris Therapeutics Inc | $110.82M | +117.09% |
| ONCY | Oncolytics Biotech Inc | $104.98M | +105.65% |
| HLVX | HilleVax Inc | $104.74M | +105.17% |
| BDTX | Black Diamond Therapeutics Inc | $103.72M | +103.17% |
| ADVM | Adverum Biotechnologies Inc | $102.40M | +100.60% |
| SPRO | Spero Therapeutics Inc | $98.42M | +92.79% |
| KZIA | Kazia Therapeutics Ltd | $97.74M | +91.46% |
| VRCA | Verrica Pharmaceuticals Inc | $97.23M | +90.47% |
| ICCC | Immucell Corp | $97.07M | +90.16% |
| PYPD | Polypid Ltd | $94.84M | +85.79% |
| BMEA | Biomea Fusion Inc | $93.27M | +82.70% |
| CUE | Cue Biopharma Inc | $92.75M | +81.68% |
| ENLV | Enlivex Ltd | $92.47M | +81.13% |
| PTHS | Channel Therapeutics Corporation | $91.66M | +79.56% |
| MAIA | MAIA Biotechnology Inc | $89.19M | +74.71% |
| NTHI | NeOnc Technologies Holdings Inc | $87.88M | +72.15% |
| ADAP | Adaptimmune Therapeutics plc American Depositary Shares | $86.99M | +70.41% |
| CRDF | Cardiff Oncology Inc | $85.46M | +67.41% |
| RLYB | Rallybio Corp | $85.33M | +67.16% |
| CGTX | Cognition Therapeutics Inc | $84.81M | +66.13% |
| LPTX | Leap Therapeutics Inc | $84.76M | +66.03% |
| ATHE | Alterity Therapeutics Ltd | $84.66M | +65.84% |
| ACET | Adicet Bio Inc | $83.31M | +63.19% |
| HRTX | Heron Therapeutics Inc | $83.25M | +63.09% |
| ENTX | Entera Bio Ltd | $82.99M | +62.56% |
| INO | Inovio Pharmaceuticals Inc | $81.63M | +59.91% |
| CSBR | Champions Oncology Inc | $80.27M | +57.23% |
| NRXS | Neuraxis Inc | $79.92M | +56.56% |
| FBIOP | Fortress Biotech Inc | $77.72M | +52.25% |
| ATHA | Athira Pharma Inc | $77.21M | +51.26% |
| PMVP | PMV Pharmaceuticals Inc | $74.66M | +46.26% |
| GLTO | Galecto Inc | $74.66M | +46.24% |
| ACRV | Acrivon Therapeutics Inc | $74.39M | +45.72% |
| ATRA | Atara Biotherapeutics Inc | $72.78M | +42.56% |
| MNMD | Mind Medicine (MindMed) Inc. Common Shares | $71.93M | +40.90% |
| GANX | Gain Therapeutics Inc | $71.38M | +39.83% |
| XBIT | XBiotech Inc | $69.82M | +36.76% |
| PLRX | Pliant Therapeutics Inc | $69.34M | +35.84% |
| HYFT | MindWalk Holdings Corp | $69.31M | +35.77% |
| MNOV | Medicinova Inc | $68.91M | +34.99% |
| SPRB | Spruce Biosciences Inc | $67.96M | +33.12% |
| IMA | Ikena Oncology Inc | $67.49M | +32.21% |
| ELTX | Elicio Therapeutics Inc | $65.05M | +27.43% |
| IMMP | Immutep Ltd | $64.23M | +25.82% |
| KLTO | Klotho Neurosciences Inc Com | $63.55M | +24.49% |
| ACHL | Achilles Therapeutics Plc | $63.22M | +23.84% |
| EDSA | Edesa Biotech Inc | $61.04M | +19.58% |
| OSTX | OS Therapies Inc | $60.88M | +19.26% |
| OKUR | Reneo Pharmaceuticals Inc - Class A | $59.20M | +15.97% |
| IBIO | iBio Inc | $58.38M | +14.36% |
| CNTX | Context Therapeutics Inc | $57.91M | +13.44% |
| OKYO | OKYO Pharma Ltd - New | $56.13M | +9.96% |
| BOLD | Boundless Bio Inc | $55.35M | +8.42% |
| CING | Cingulate Inc | $54.66M | +7.07% |
| KZR | Kezar Life Sciences Inc | $53.76M | +5.31% |
| XLO | Xilio Therapeutics Inc | $52.74M | +3.31% |
| MREO | Mereo Biopharma Group Plc | $52.58M | +3.00% |
| ATYR | Atyr Pharma Inc | $52.39M | +2.62% |
| MCRB | Seres Therapeutics Inc | $52.28M | +2.41% |
| BYSI | BeyondSpring Inc | $52.22M | +2.30% |
| EXOZ | Invizyne Technologies Inc | $51.89M | +1.65% |
| RNTX | Rein Therapeutics Inc | $51.79M | +1.46% |
| TIL | Instil Bio Inc | $51.68M | +1.23% |
| ANVS | Annovis Bio Inc | $51.65M | +1.18% |
| GOSS | Gossamer Bio Inc | $51.14M | +0.18% |
| IBO | Impact BioMedical Inc | $50.13M | -1.81% |
| MGX | Metagenomi Inc | $48.56M | -4.87% |
| DWTX | Virios Therapeutics Inc | $48.10M | -5.78% |
| LVTX | LAVA Therapeutics NV | $45.77M | -10.34% |
| TELO | Telomir Pharmaceuticals Inc | $45.73M | -10.43% |
| DYAI | Dyadic International Inc DE | $44.46M | -12.92% |
| PDSB | PDS Biotechnology Corporation | $41.64M | -18.43% |
| APLM | Apollomics Inc - Class A | $41.33M | -19.04% |
| ACTU | Actuate Therapeutics Inc | $40.78M | -20.11% |
| FGEN | FibroGen Inc | $39.31M | -23.00% |
| GRCE | Acasti Pharma Inc | $38.94M | -23.72% |
| VERU | Veru Inc | $38.84M | -23.91% |
| RNXT | RenovoRx Inc | $38.73M | -24.14% |
| NNVC | NanoViricides Inc | $37.23M | -27.07% |
| NTRB | Nutriband Inc | $37.08M | -27.37% |
| RADX | Radiopharm Theranostics Ltd | $36.10M | -29.27% |
| GBIO | Generation Bio Company | $35.97M | -29.54% |
| GNTA | Genenta Science SpA | $35.85M | -29.77% |
| ALGS | Aligos Therapeutics Inc | $35.71M | -30.06% |
| MURA | Mural Oncology plc | $35.34M | -30.77% |
| LTRN | Lantern Pharma Inc | $34.89M | -31.65% |
| LITS | Lite Strategy Inc | $34.77M | -31.88% |
| HYPD | Eyenovia Inc | $34.51M | -32.39% |
| LSTA | Lisata Therapeutics Inc | $34.15M | -33.10% |
| ABVC | ABVC BioPharma Inc | $32.98M | -35.39% |
| ESLA | Estrella Immunopharma Inc | $32.50M | -36.33% |
| SNTI | Senti Biosciences Inc | $32.39M | -36.55% |
| DARE | Dare Bioscience Inc | $30.14M | -40.96% |
| SER | AgeX Therapeutics Inc | $29.05M | -43.09% |
| SGMO | Sangamo Therapeutics Inc | $28.83M | -43.52% |
| BCTX | BriaCell Therapeutics Corp - New | $28.57M | -44.04% |
| ATNM | Actinium Pharmaceuticals Inc | $28.56M | -44.05% |
| CRVO | CervoMed Inc | $28.42M | -44.32% |
| PSTV | Plus Therapeutics Inc | $28.00M | -45.16% |
| TVRD | Cara Therapeutics Inc | $27.49M | -46.15% |
| BRNS | Barinthus Biotherapeutics Plc. | $26.44M | -48.21% |
| IGC | IGC Pharma Inc | $26.36M | -48.37% |
| EVAX | Evaxion Biotech A/S | $25.44M | -50.17% |
| VYNE | VYNE Therapeutics Inc | $25.25M | -50.53% |
| GRDX | Entero Therapeutics Inc | $24.74M | -51.54% |
| NXTC | Nextcure Inc | $23.92M | -53.15% |
| MRKR | Marker Therapeutics Inc | $23.55M | -53.87% |
| NRSN | NeuroSense Therapeutics Ltd | $23.41M | -54.15% |
| CELU | Celularity Inc - Class A | $22.49M | -55.94% |
| COEP | Coeptis Therapeutics Holdings Inc. Common Stock | $21.96M | -56.99% |
| OPT | Opthea Ltd | $21.53M | -57.83% |
| SKYE | Skye Bioscience Inc | $21.29M | -58.29% |
| PLRZ | Polyrizon Ltd | $21.02M | -58.82% |
| ATOS | Atossa Therapeutics Inc | $21.01M | -58.84% |
| PHXM | PHAXIAM Therapeutics SA ADR | $20.38M | -60.08% |
| TVGN | Tevogen Bio Holdings Inc | $19.93M | -60.97% |
| SNSE | Sensei Biotherapeutics Inc | $19.48M | -61.85% |
| JSPR | Jasper Therapeutics Inc | $19.37M | -62.05% |
| KALA | Kala Bio Inc | $19.15M | -62.49% |
| NEUP | Neuphoria Therapeutics Inc | $18.93M | -62.92% |
| NCEL | NLS Pharmaceutics Ltd | $18.85M | -63.07% |
| ALLR | Allarity Therapeutics Inc | $18.67M | -63.43% |
| ICU | SeaStar Medical Holding Corp | $18.45M | -63.86% |
| PLUR | Pluri Inc | $18.25M | -64.24% |
| LPCN | Lipocine Inc | $17.64M | -65.44% |
| QNTM | FSD Pharma Inc - Class B - Class B (Sub Voting) | $17.55M | -65.61% |
| HOWL | Werewolf Therapeutics Inc | $16.50M | -67.68% |
| HIND | ReShape Lifesciences Inc | $15.93M | -68.79% |
| PTN | Palatin Technologies Inc | $15.81M | -69.03% |
| PASG | Passage Bio Inc | $15.75M | -69.15% |
| LGVN | Longeveron Inc - Class A | $15.75M | -69.15% |
| CYCN | Cyclerion Therapeutics Inc | $15.74M | -69.18% |
| TPST | Tempest Therapeutics Inc | $15.35M | -69.93% |
| CLRB | Cellectar Biosciences Inc | $14.97M | -70.68% |
| APLT | Applied Therapeutics Inc | $14.86M | -70.88% |
| HOTH | Hoth Therapeutics Inc | $14.64M | -71.31% |
| LEXX | Lexaria Bioscience Corp | $14.58M | -71.44% |
| IOBT | IO Biotech Inc | $14.50M | -71.60% |
| HOOK | Hookipa Pharma Inc | $14.43M | -71.74% |
| INAB | IN8bio Inc | $14.18M | -72.22% |
| OSRH | Bellevue Life Sciences Acquisition Corp | $14.00M | -72.58% |
| ANEB | Anebulo Pharmaceuticals, Inc. Common Stock | $13.82M | -72.93% |
| BIVI | BioVie Inc - Class A | $13.35M | -73.85% |
| BLRX | Bioline Rx Ltd | $13.35M | -73.86% |
| LNAI | Lunai Bioworks Inc | $13.33M | -73.90% |
| COCP | Cocrystal Pharma Inc | $13.24M | -74.07% |
| QNCX | Quince Therapeutics Inc | $13.03M | -74.47% |
| LSB | LakeShore Biopharma Co Ltd | $13.02M | -74.49% |
| GTBP | GT Biopharma Inc | $12.33M | -75.85% |
| MBRX | Moleculin Biotech Inc | $12.33M | -75.85% |
| CALC | CalciMedica Inc | $12.31M | -75.89% |
| INTS | Intensity Therapeutics Inc | $12.30M | -75.91% |
| AIM | AIM ImmunoTech Inc. | $12.01M | -76.47% |
| KTTA | Pasithea Therapeutics Corp | $11.92M | -76.65% |
| QNRX | Quoin Pharmaceuticals Ltd | $11.92M | -76.65% |
| CTXR | Citius Pharmaceuticals Inc | $11.88M | -76.72% |
| GDTC | CytoMed Therapeutics Ltd | $11.32M | -77.82% |
| TOVX | Theriva Biologics Inc | $11.15M | -78.16% |
| CMMB | Chemomab Therapeutics Ltd | $10.93M | -78.58% |
| BCLI | Brainstorm Cell Therapeutics Inc | $10.73M | -78.97% |
| KLTOW | Klotho Neurosciences Inc Wt Exp | $10.43M | -79.58% |
| PHIO | Phio Pharmaceuticals Corp | $10.34M | -79.74% |
| XCUR | Exicure Inc | $10.33M | -79.77% |
| CVM | Cel-Sci Corp | $10.15M | -80.13% |
| MLEC | Moolec Science SA | $10.06M | -80.30% |
| KPRX | Kiora Pharmaceuticals Inc | $9.90M | -80.60% |
| BCDA | BioCardia Inc | $9.59M | -81.22% |
| MTVA | MetaVia Inc | $9.55M | -81.28% |
| VTGN | VistaGen Therapeutics Inc | $9.48M | -81.44% |
| CRIS | Curis Inc | $9.45M | -81.48% |
| TRAW | Traws Pharma Inc | $9.16M | -82.05% |
| ASBP | Aspire Biopharma Holdings Inc | $9.03M | -82.31% |
| EPIX | Essa Pharma Inc | $8.93M | -82.51% |
| SONN | Sonnet BioTherapeutics Holdings Inc | $8.92M | -82.53% |
| IMNN | Imunon Inc | $8.71M | -82.94% |
| BRTX | BioRestorative Therapies Inc | $8.66M | -83.03% |
| APRE | Aprea Therapeutics Inc | $8.48M | -83.39% |
| ADXN | Addex Therapeutics Ltd | $8.21M | -83.93% |
| SYBX | Synlogic Inc | $8.20M | -83.93% |
| IMRN | Immuron Ltd | $8.15M | -84.03% |
| BOLT | Bolt Biotherapeutics Inc | $8.09M | -84.15% |
| ITRM | Iterum Therapeutics Plc | $8.06M | -84.21% |
| RNAZ | TransCode Therapeutics Inc | $7.97M | -84.38% |
| ERNA | Ernexa Therapeutics Inc | $7.85M | -84.63% |
| PMCB | PharmaCyte Biotech Inc | $7.57M | -85.17% |
| RVPH | Reviva Pharmaceuticals Holdings Inc | $7.49M | -85.34% |
| XTLB | X.T.L. Biopharmaceuticals Ltd | $7.34M | -85.63% |
| AEON | AEON Biopharma Inc - Class A | $7.31M | -85.68% |
| BCAB | BioAtla Inc | $7.07M | -86.15% |
| CANF | Can-Fite Biopharma Ltd | $6.87M | -86.53% |
| KAPA | Kairos Pharma Ltd | $6.75M | -86.78% |
| XBIO | Xenetic Biosciences Inc | $6.65M | -86.97% |
| JUNS | Jupiter Neurosciences Inc | $6.48M | -87.31% |
| PCSA | Processa Pharmaceuticals Inc | $6.40M | -87.46% |
| GOVX | Geovax Labs Inc | $6.29M | -87.69% |
| CURX | Curanex Pharmaceuticals Inc | $6.11M | -88.04% |
| PPBT | Purple Biotech Ltd | $6.05M | -88.15% |
| HCWB | HCW Biologics Inc | $6.02M | -88.20% |
| APM | Aptorum Group Limited Class A Ordinary Shares | $6.01M | -88.22% |
| ACXP | Acurx Pharmaceuticals Inc | $5.93M | -88.38% |
| CVKD | Cadrenal Therapeutics Inc | $5.89M | -88.46% |
| PULM | Pulmatrix Inc | $5.73M | -88.77% |
| EVGN | Evogene Ltd | $5.64M | -88.95% |
| APVO | Aptevo Therapeutics Inc | $5.50M | -89.22% |
| CDIO | Cardio Diagnostics Holdings Inc | $5.30M | -89.62% |
| SILO | SILO Pharma Inc | $5.29M | -89.64% |
| DRMA | Dermata Therapeutics Inc | $5.23M | -89.76% |
| LIMN | Liminatus Pharma Inc | $5.14M | -89.93% |
| TCRT | Alaunos Therapeutics Inc | $5.07M | -90.08% |
| BGMS | Bio Green Med Solution Inc | $5.00M | -90.21% |
| NCNA | NuCana plc | $4.99M | -90.22% |
| TTNP | Titan Pharmaceuticals Inc (de) | $4.91M | -90.38% |
| CLGN | CollPlant Biotechnologies Ltd New | $4.80M | -90.60% |
| ALZN | Alzamend Neuro Inc | $4.68M | -90.83% |
| GNPX | Genprex Inc | $4.44M | -91.30% |
| CASI | CASI Pharmaceuticals Inc | $4.27M | -91.64% |
| ENTO | Entero Therapeutics, Inc. Common Stock | $4.26M | -91.65% |
| REVB | Revelation Biosciences Inc | $4.26M | -91.65% |
| MBIO | Mustang Bio Inc | $4.25M | -91.67% |
| ADIL | Adial Pharmaceuticals Inc | $4.24M | -91.69% |
| ENVB | Enveric Biosciences Inc | $4.15M | -91.87% |
| CNSP | Cns Pharmaceuticals Inc | $4.14M | -91.89% |
| SXTP | 60 Degrees Pharmaceuticals Inc | $4.09M | -91.99% |
| SNGX | Soligenix Inc | $3.91M | -92.34% |
| PBM | Psyence Biomedical Ltd | $3.76M | -92.63% |
| CELZ | Creative Medical Technology Holdings Inc | $3.70M | -92.76% |
| GLMD | Galmed Pharmaceuticals Ltd | $3.38M | -93.38% |
| XRTX | XORTX Therapeutics Inc | $3.34M | -93.45% |
| FBLG | FibroBiologics Inc | $3.18M | -93.77% |
| SLXN | Silexion Therapeutics Corp | $3.11M | -93.91% |
| SPRC | SciSparc Ltd | $3.05M | -94.03% |
| BDRX | Biodexa Pharmaceuticals Plc | $2.98M | -94.16% |
| AFMD | Affimed N.V. | $2.98M | -94.17% |
| ENSC | Ensysce Biosciences Inc | $2.88M | -94.37% |
| ARTL | Artelo Biosciences Inc | $2.75M | -94.62% |
| GRI | GRI Bio Inc | $2.57M | -94.97% |
| ONCO | Onconetix Inc | $2.54M | -95.03% |
| PPCB | Propanc Biopharma Inc | $2.50M | -95.10% |
| VIVS | VivoSim Labs Inc | $2.47M | -95.16% |
| OGEN | Oragenics Inc | $2.45M | -95.20% |
| NBY | Stablecoin Development Corp | $2.40M | -95.29% |
| NTBL | Notable Labs Inc Ord | $2.39M | -95.31% |
| BBLG | Bone Biologics Corp | $2.23M | -95.64% |
| AZTR | Azitra Inc | $2.22M | -95.64% |
| MTNB | Matinas Biopharma Holdings Inc | $2.18M | -95.72% |
| CLSD | Clearside Biomedical, Inc. Common Stock | $2.15M | -95.80% |
| CMND | Clearmind Medicine Inc | $2.12M | -95.86% |
| QLGN | Qualigen Therapeutics, Inc. Common Stock | $2.09M | -95.91% |
| CLDI | Calidi Biotherapeutics Inc | $1.99M | -96.09% |
| ONCT | Oncternal Therapeutics Inc | $1.56M | -96.95% |
| VRAX | Virax Biolabs Group Ltd - Class A | $1.52M | -97.02% |
| ABP | Abpro Holdings, Inc Common Stock | $1.43M | -97.21% |
| JAGX | Jaguar Health Inc | $1.34M | -97.37% |
| ZVSA | ZyVersa Therapeutics Inc | $1.03M | -97.98% |
| LYRA | Lyra Therapeutics Inc | $927198.36 | -98.18% |
| SCNI | Scinai Immunotherapeutics Ltd | $912143.15 | -98.21% |
| TNFA | TNF Pharmaceuticals Inc | $551031.39 | -98.92% |
| PTIX | Protagenic Therapeutics Inc | $503648.74 | -99.01% |
| SLRX | Decoy Therapeutics Inc | $446853.12 | -99.12% |
| ELAB | PMGC Holdings Inc | $221376.00 | -99.57% |
| CDT | CDT Equity Inc | $110551.31 | -99.78% |
| ADTX | Aditxt Inc | $98471.97 | -99.81% |